The global clinical trials market is anticipated to grow at a considerable CAGR of 5.3% during the forecast period. The key factors that are contributing to the market growth are the adoption of several strategies by companies operating in the market for clinical trials market. For instance,
Browse the full report description of “Clinical Trials Market Size, Share & Trends Analysis Report by Phase (Phase I, Phase II, Phase III, and Phase IV), by Study Design (Interventional, Observational, and Expanded Access), by Therapeutic Area (Autoimmune Disease, Oncology, Cardiology, Infectious Disease, Dermatology, Ophthalmology, and Others) and by Sponsor Outlook (Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, and Others) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/clinical-trials-market
• In June 2022, Walgreens launched its clinical trial business to increase access and retention in sponsor-led drug development research and redefine the patient experience. The company with this expansion is rapidly scaling three portfolio-integrated, patient-centric.
• In March 2022, CCT Research added a new innovative Decentralized Clinical Trial (DCT) team, to expand its reach and management of clinical trials by providing expert support to all subjects and sites. DCT is focused on supporting a positive subject experience and delivering exceptional quality data.
• In April 2021, Calyx has launched Calyx CTMS v15.0, an advanced clinical trial management system that reduces risk and improves efficiencies in clinical development. It is Microsoft's Azure cloud technology that simplifies the oversight of clinical trial operations and improves data quality.
• In April 2021, Parexel and Veeva Systems have collaborated to accelerate clinical trials through technology and process innovation. In this new partnership, Parexel is dependent on Veeva’s suite of clinical operations applications, such as Veeva Vault eTMF, Vault CTMS, Vault Study Startup, and Veeva Vault CDMS for clinical data management.
• In April 2021, Cofactor Genomics has began the first multicenter clinical trial of its OncoPrism immunotherapy response prediction assay, which is developed using the company's proprietary immune modeling technology.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Phase
o By Study Design
o By Therapeutic Area
o By Sponsor Outlook
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- AccuLab Life Sciences, Charles River Laboratories International, Inc., Eli Lilly and Co., Labcorp, Parexel International GmbH, Pfizer Inc., WuXi AppTec Co., Ltd., and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Clinical Trials Market Report Segment
By Phase
By Study Design
By Therapeutic Area
By Sponsor Outlook
Global Clinical Trials Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/clinical-trials-market